These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 16104682)

  • 1. Clinical implications of the ethics of informed consent for first-trimester risk assessment for trisomy 21.
    Chervenak FA; McCullough LB; Chasen ST
    Semin Perinatol; 2005 Aug; 29(4):277-9. PubMed ID: 16104682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical considerations of early (first vs. second trimester) risk assessment disclosure for trisomy 21 and patient choice in screening versus diagnostic testing.
    Sharma G; McCullough LB; Chervenak FA
    Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):99-104. PubMed ID: 17299736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethics is an essential dimension of first-trimester risk assessment for trisomy 21.
    Chervenak FA; McCullough LB
    Semin Ultrasound CT MR; 2008 Apr; 29(2):132-5. PubMed ID: 18450138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical considerations in first-trimester Down syndrome risk assessment.
    Chervenak FA; McCullough LB
    Curr Opin Obstet Gynecol; 2010 Apr; 22(2):135-8. PubMed ID: 20125014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21.
    Nicolaides KH; Chervenak FA; McCullough LB; Avgidou K; Papageorghiou A
    Am J Obstet Gynecol; 2005 Aug; 193(2):322-6. PubMed ID: 16098850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of first-trimester risk assessment for trisomy 21: ethical considerations.
    Chervenak FA; McCullough LB
    Am J Obstet Gynecol; 2005 Jun; 192(6):1777-81. PubMed ID: 15970806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester risk assessment: twin gestations.
    Platt LD
    Semin Perinatol; 2005 Aug; 29(4):258-62. PubMed ID: 16104678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
    Sepulveda W; Wong AE; Dezerega V
    Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
    Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
    Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
    Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?
    Comstock CH; Malone FD; Ball RH; Nyberg DA; Saade GR; Berkowitz RL; Ferreira J; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Bianchi DW; D'Alton ME;
    Am J Obstet Gynecol; 2006 Sep; 195(3):843-7. PubMed ID: 16949423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of maternal smoking on prenatal screening for Down syndrome and trisomy 18 in the first trimester of pregnancy.
    Miron P; Côté YP; Lambert J
    Prenat Diagn; 2008 Mar; 28(3):180-5. PubMed ID: 18264956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-trimester prenatal screening for trisomy 21 using biochemical markers: a 7-year experience in one cytogenetic laboratory.
    Marical H; Douet-Guilbert N; Bages K; Collet M; Le Bris MJ; Morel F; De Braekeleer M
    Prenat Diagn; 2006 Apr; 26(4):308-12. PubMed ID: 16491510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in northern Finland.
    Valinen Y; Rapakko K; Kokkonen H; Laitinen P; Tekay A; Ahola T; Ryynanen M
    Am J Obstet Gynecol; 2007 Mar; 196(3):278.e1-5. PubMed ID: 17346554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing patient autonomy with risk assessment and invasive diagnosis: an ethical solution to a clinical challenge.
    Chervenak FA; McCullough LB; Sharma G; Davis J; Gross S
    Am J Obstet Gynecol; 2008 Jul; 199(1):19.e1-4. PubMed ID: 18355783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pregnant women's assessment and level of knowledge of prenatal counseling].
    Tschudin S; Holzgreve W; Conde N; Alder J; Bitzer J; Tercanli S
    Ultraschall Med; 2009 Apr; 30(2):157-62. PubMed ID: 18484059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of first and second trimester aneuploidy risk assessment.
    Reddy UM; Wapner RJ
    Clin Obstet Gynecol; 2007 Jun; 50(2):442-53. PubMed ID: 17513930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.